Strata Critical Medical (SRTA) Net Cash Flow (2019 - 2026)

Strata Critical Medical has disclosed Net Cash Flow across 8 years of filings, most recently posting $27.8 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 74.4% year-over-year to $27.8 million; the TTM figure through Mar 2026 stood at $23.8 million (up 1072.34% YoY), while the FY2025 annual figure was $11.9 million, up 228.3% from the prior year.
• Net Cash Flow rose to $27.8 million in Q1 2026, from $8.2 million in the prior quarter.
• Over the last five years, Net Cash Flow for SRTA reached as high as $185.0 million in Q2 2022 and fell as low as -$36.7 million in Q3 2025.
• The 5-year median for Net Cash Flow is -$607000.0 (2023), against an average of $13.4 million.
• The widest YoY moves for Net Cash Flow: up 1593.41% in 2024, down 589.78% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $185.0 million in 2022, then sank by 105.01% to -$9.3 million in 2023, then soared by 82.2% to -$1.6 million in 2024, then surged by 597.94% to $8.2 million in 2025, then jumped by 237.82% to $27.8 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $27.8 million, $8.2 million, and -$36.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.